The known immunologically active components of Astragalus account for only a small proportion of the immunological adjuvant activity when combined with conjugate vaccines

Planta Medica

Volumn 77, Issue 8, 2011, Pages 817-824

  Hong, Feng ^a   Xiao, Weilie ^b   Ragupathi, Govind ^a   Lau, Clara B S ^c   Leung, Ping Chung ^c   Yeung, K Simon ^a   George, Constantine ^a   Cassileth, Barrie ^a   Kennelly, Edward ^b   Livingston, Philip O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

astragalosides; Astragalus membranaceus; botanicals; cancer vaccine; conjugate vaccine; Leguminosae; saponin

Indexed keywords

ANTIGEN; ASTRAGALOSIDE I; ASTRAGALOSIDE II; ASTRAGALOSIDE IV; ASTRAGALUS EXTRACT; BETA GLUCAN; CALYCOSIN; CALYCOSIN 7 O BETA DEXTRO GLUCOSIDE; ENDOTOXIN; FORMONONETIN; FORMONONETIN 7 O BETA DEXTRO GLUCOSIDE; GANGLIOSIDE GD3; GLOBO H ANTIGEN; ISOQUERCITRIN; ISOQUERCITRIN 3 BETA GLUCOSIDE; ISOQUERCITRIN 7 O BETA DEXTRO GLUCOSIDE; ISORHAMNETIN 3 O BETA GLUCOSIDE; KEYHOLE LIMPET HEMOCYANIN; MUCIN 1; ONONIDE ONONIN; OPT 821; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; DRUG POTENCY; FEMALE; IMMUNIZATION; IMMUNOMODULATION; MOUSE; NONHUMAN; SOLVENT EXTRACTION; WEIGHT REDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, NEOPLASM; ANTIBODY FORMATION; ASTRAGALUS MEMBRANACEUS; CANCER VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLAVONOIDS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLANT EXTRACTS; SAPONINS; TRITERPENES; VACCINES, CONJUGATE;

ASTRAGALUS (ANGIOSPERM); ASTRAGALUS MEMBRANACEUS; FABACEAE; MUS;

EID: 79957520159     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250574     Document Type: Article

References (27)

1. Ragupathi G, Park T K., Zhang S, Kim I J., Graeber K, Adluri S, Lloyd K O., Danishefsky S J., Livingston P O. Immunization of mice with the synthetic hexasaccharide Globo H results in antibodies against human cancer cells. Angew Chem Int Ed Engl 1997 36 125-128
2. Kim S K., Ragupathi G, Cappello S, Kagan E, Livingston P O. Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates. Vaccine 2000 19 530-537
3. Ragupathi G, Yeung K S., Leung P C., Lee M, Lau C B., Vickers A, Hood C, Deng G, Cheung N K., Cassileth B, Livingston P. Evaluation of widely consumed botanicals as immunological adjuvants. Vaccine 2008 26 4860-4865
4. Ross G D., Vetvicka V, Yan J, Xia Y, Vetvickova J. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology 1999 42 61-74 (Pubitemid 29322289)
5. [No authors listed]. Astragalus membranaceus. Monograph. Altern Med Rev 2003 8 72-77
6. Chu K K., Ho S S., Chow A H. Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values. J Clin Pharmacol 2002 42 976-984 (Pubitemid 34920795)
7. Spellman K, Burns J, Nichols D, Winters N, Ottersberg S, Tenborg M. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev 2006 11 128-150 (Pubitemid 44050251)
8. Kamiyama H, Takano S, Ishikawa E, Tsuboi K, Matsumura A. Anti-angiogenic and immunomodulatory effect of the herbal medicine Juzen-taiho-to on malignant glioma. Biol Pharm Bull 2005 28 2111-2116 (Pubitemid 41634261)
9. Matsumoto T, Sakurai M H., Kiyohara H, Yamada H. Orally administered decoction of Kampo (Japanese herbal) medicine, Juzen-Taiho-To modulates cytokine secretion and induces NKT cells in mouse liver. Immunopharmacology 2000 46 149-161 (Pubitemid 30019256)
10. Kodama N, Komuta K, Nanba H. Can maitake MD-fraction aid cancer patients? Altern Med Rev 2002 7 236-239 (Pubitemid 34747611)
11. Smith J E. S. R. Immunomodulatory activities of mushroom glucans and polysaccharide-protein complexes in animals and humans, Chapter 6. London Cancer Res UK 2002 106
12. Maheshwari R K., Singh A K., Gaddipati J, Srimal R C. Multiple biological activities of curcumin: a short review. Life Sci 2006 78 2081-2087
13. Xiao W, Wang Q, Unachukwu U, Lau C B., Jiang B, Hong F, Leung P C., Motley T, Livingston P, Cassileth B, Kennelly E. Chemical and genetic assessment of commercial Radix Astragali (Astragalus spp.) by ion trap LC-MS and nuclear ribosomal DNA sequence analyses. J Agric Food Chem, in press
14. Ragupathi G, Cappello S, Yi S S., Canter D, Spassova M, Bornmann W G., Danishefsky S J., Livingston P O. Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines. Vaccine 2002 20 1030-1038 (Pubitemid 34135937)
15. Ragupathi G, Meyers M, Adluri S, Howard L, Musselli C, Livingston P O. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21. Int J Cancer 2000 85 659-666 (Pubitemid 30080479)
16. Gilewski T, Adluri S, Ragupathi G, Zhang S, Yao T J., Panageas K, Moynahan M, Houghton A, Norton L, Livingston P O. Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. Clin Cancer Res 2000 6 1693-1701 (Pubitemid 30305061)
17. Kim S K., Ragupathi G, Musselli C, Choi S J., Park Y S., Livingston P O. Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines. Vaccine 1999 18 597-603 (Pubitemid 29509842)
18. Livingston P O., Adluri S, Helling F, Yao T J., Kensil C R., Newman M J., Marciani D. Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine 1994 12 1275-1280
19. Chu D T., Wong W L., Mavligit G M. Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo. J Clin Lab Immunol 1988 25 125-129
20. Sun H X., Qin F, Ye Y P. Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng. Vaccine 2005 23 5533-5542 (Pubitemid 41608602)
21. Yang Z G., Sun H X., Fang W H. Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice. Vaccine 2005 23 5196-5203
22. Leung A Y., Foster S. Encyclopedia of common natural ingredients used in food, drugs and cosmetics, 2nd edition. New York, NY John Wiley & Sons 1996
23. Upton R S. C. Astragalus root: Analytical, quality control, and therapeutic monograph. Scotts Valley American Herbal Pharmacopoeia 1999 1-25
24. Kim Y J., Wang P, Navarro-Villalobos M, Rohde B D., Derryberry J, Gin D Y. Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi. J Am Chem Soc 2006 128 11906-11915 (Pubitemid 44360227)
25. Liu J, Hu X, Yang Q, Yu Z, Zhao Z, Yi T, Chen H. Comparison of the immunoregulatory function of different constituents in radix astragali and radix hedysari. J Biomed Biotechnol 2010 2010 479426
26. Qi L W., Yu Q T., Li P, Li S L., Wang Y X., Sheng L H., Yi L. Quality evaluation of Radix Astragali through a simultaneous determination of six major active isoflavonoids and four main saponins by high-performance liquid chromatography coupled with diode array and evaporative light scattering detectors. J Chromatogr A 2006 1134 162-169 (Pubitemid 44740252)
27. Yu Q T., Qi L W., Li P, Yi L, Zhao J, Bi Z. Determination of seventeen main flavonoids and saponins in the medicinal plant Huang-qi (Radix astragali) by HPLC-DAD-ELSD. J Sep Sci 2007 30 1292-1299 (Pubitemid 46979326)